SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

February, 2024

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                           Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                           No x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 

 

 

 

 

EXHIBITS

 

Exhibit
Number

  Description of Exhibits
     
99.1   Intimation on results of voting results through postal ballot dated February 14, 2024

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

     
Date: February 14, 2024      By: /s/ K Randhir Singh
    Name:  K Randhir Singh
    Title: Company Secretary

 

 

 

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN : L85195TG1984PLC004507

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

February 14, 2024

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub:Results of voting through Postal Ballot (remote e-voting) pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

 

This is in furtherance to our letter dated January 15, 2024 enclosing therein Notice of Postal Ballot for seeking approval of Members of the Company, regarding the appointment of Mr. Sanjiv Soshil Mehta (DIN: 06699923) as an Independent Director of the Company, effective from December 29, 2023 in terms of Section 149 of the Companies Act, 2013, by way of special resolution through voting by electronic means (remote e-voting).

 

We would like to inform that the special resolution mentioned in the said Postal Ballot Notice have been passed by the Members of the Company with requisite majority.

 

In accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summarized voting result of the remote e-voting, in the prescribed format, along with a copy of the Scrutinizer’s Report are enclosed herewith, for your information and records. The same is also being made available on the Company’s website, www.drreddys.com.

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

K Randhir Singh  
Company Secretary, Compliance Officer and Head-CSR  

 

CC: National Securities Depositary Limited (NSDL)

 

 

 

  

 

COMPANY SECRETARIES

201-206. SHIV SMRITI, 2ND FLOOR, 49/A, DR. ANNIE BESANT ROAD, ABOVE CORPORATION BANK, WORLI, MUMBAI - 400 018

TEL : +91-22-6611 9696, • E-mail: dipti@mehta-mehta.com • Visit us; www.mehta-mehta.com

AUTHORISED AGENTS FOR TRADEMARK, COPYRIGHT AND PATENT

 

Scrutinizer’s Report

[Pursuant to Section 108 and 110 of the Companies Act, 2013 and
Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014]

 

To,

The Chairman

Dr. Reddy’s Laboratories Limited

8-2-337, Road No. 3, Banjara Hills,

Hyderabad, Telangana- 500034

 

Sub: Scrutinizer’s Report on voting through E-voting for Postal Ballot in terms of Section 108 and 110 of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014

 

Dear Sir,

 

I, Atul Mehta, Partner, M/s, Mehta & Mehta, Practicing Company Secretaries have been appointed as a Scrutinizer by the Board of Directors of Dr. Reddy’s Laboratories Limited (“Company”) for the purpose of scrutinizing the Postal Ballot remote e-voting process carried out by the Company as per Section 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 and Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 read with the General Circular No. 14/2020 dated April 8, 2020, the General Circular No. 17/2020 dated April 13, 2020, and the General Circular No. 22/2020 dated June 15, 2020, the General Circular No. 33/2020 dated September 28, 2020, the General Circular No. 3 9/2020 dated December 31, 2020, the General Circular No. 10/2021 dated June 23, 2021 and the General Circular No. 20/2021 dated December 8, 2021, General Circular No. 03/2022 dated May 05, 2022, General Circular No. 11/2022 dated December 28, 2022 and General Circular No. 09/2023 dated September 25, 2023, issued by the Ministry of Corporate Affairs, Government of India (the “MCA Circulars”), Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Secretarial Standards on General Meetings (“SS-2”) issued by the Institute of Company Secretaries of India on the resolution as mentioned in the Notice of Postal Ballot dated Friday, January 12, 2024,in a fair and transparent manner and do hereby submit the report as under:

 

1.The Notice of Postal Ballot (“Notice”) was dispatched to the members of the Company vide e-mail on Monday, January 15, 2024.

 

 

 

 

 

 

2.The remote e-voting period commenced on Tuesday, January 16, 2024 (09.00 a.m. 1ST) and ended on Wednesday, February 14, 2024 (05:00 p.m. 1ST).

 

3.The remote e-voting facility was provided by National Securities Depository Limited (NSDL).

 

4.The Notice of Postal Ballot was sent in electronic form only to all the shareholders whose email addresses are registered with Company/Depositories and whose names appear in the Register of Members/ List of Beneficial Owners as received from Depositories i.e. National Securities Depository Limited/ Central Depository Services (India) Limited.

 

5.The hard copies of the Notice along with Postal Ballot forms and pre-paid business envelope were not sent to the Members for the Postal Ballot in accordance with the requirements specified under the MCA Circulars. Accordingly, the communication of the assent or dissent of the Members took place through the remote e-voting system only.

 

6.The Members of the Company holding shares as on the cut-off date i.e., Friday, January 12, 2024, were entitled to vote on the proposed resolution.

 

7.The register, in accordance with Rule 20(4)(xiv) and Rule 22(10) of the Companies (Management & Administration) Rules, 2015, has been maintained electronically to record the assent or dissent received, mentioning the particulars of name, address, folio number or client ID of the shareholders, number of shares held by them. There were no shares with differential voting rights in the Company, hence there is no requirement of maintaining of the list of shares with differential voting rights.

 

8.The related papers with respect to Postal Ballot will be handed over to the Company for safe custody of the same after the Chairman or any person authorized by him, signs the minutes/report of Postal Ballot process.

 

9.The result of the scrutiny of the above postal ballot through remote e-voting in respect of passing of resolution contained in the Notice dated Friday, January 12, 2024 is as under:

 

A.Special Resolution — Approval of the appointment of Mr. Sanjiv Soshil Mehta (DIN: 06699923) as an Independent Director of the Company, in terms of Section 149 of the Companies Act, 2013

 

 

 

 

 

 

Votes in favour of the resolution:

 

Number of members
who voted
  Number of votes cast by
them
   % of total number of valid
votes cast
 
2,575   13,22,96,356    99.76%

 

Votes against the resolution:

 

Number of members
who voted
  Number of votes cast by
them
   % of total number of valid
votes cast
 
86   3,16,136    0.24%

 

Invalid/Abstained votes:

 

Total number of members whose votes were declared invalid/abstained  Total number of votes cast by them 
0   0 

 

The Special resolution has been passed, since the votes casted in favour of the resolution are more than three times the votes against the resolution.

 

Thanking You,

 

For Mehta & Mehta

Company Secretaries

 

/s/ Atul Mehta  
Atul Mehta
Scrutinizer
FCS No: 5782
CP No: 2486
UDIN: F005782E003432183
PR No.: 3686/2023
Place: Mumbai
Date: February 14, 2024

 

Countersigned by

   
(Person authorized by Chairman)
K Randhir Singh  

Company Secretary, Compliance Officer, and Head- CSR

Dr, Reddys Laboratories Limited

Membership No: F6621

Place: Hyderabad

Date: February 14, 2024

 

 

 

 

General information about company
Scrip code 500124
NSE Symbol DRREDDY
MSEI Symbol NOTLISTED
ISIN INE089A01023
Name of the company Dr. Reddy's Laboratories Limited
Type of meeting Postal Ballot
Date of the meeting / last day of receipt of postal ballot forms (in case of Postal Ballot) 14-02-2024
Start time of the meeting  
End time of the meeting  

 

Scrutinizer Details
Name of the Scrutinizer Atul Mehta
Firms Name Mehta & Mehta
Qualification CS
Membership Number F5782
Date of Board Meeting in which appointed 29-12-2023
Date of Issuance of Report to the company 14-02-2024

 

Voting results

Record date

12-01-2024

Total number of shareholders on record date 272623
No. of shareholders present in the meeting either in person or through proxy

a) Promoters and Promoter group

 
b) Public  
No. of shareholders attended the meeting through video conferencing

a) Promoters and Promoter group

 
b) Public  
No. of resolution passed in the meeting 1

 

 

 

 

 

 

Resolution (1)
Resolution required: (Ordinary / Special) Special
Whether promoter/promoter group are interested in the agenda/resolution? No
Description of resolution considered Approval of the appointment of Mr. Sanjiv Soshil Mehta (DIN: 06699923) as an Independent Director of the Company, in terms of Section 149 of the Companies Act, 2013

 

Category  Mode of voting  No. of shares
held
   No. of votes
polled
   % of Votes
polled on
outstanding
shares
   No. of votes – in
favour
   No. of votes –
against
   % of votes in
favour on votes
polled
   % of Votes
against on votes
polled
 
      (1)   (2)   (3)=[(2)/(1)]*100   (4)   (5)   (6)=[(4)/(2)]*100   (7)=[(5)/(2)]*100 
   E-Voting        44461128    100.0000    44461128    0    100.0000    0.0000 
Promoter and
Promoter Group
  Poll   44461128    0    0.0000    0    0    0    0 
  Postal Ballot (if applicable)        0    0.0000    0    0    0    0 
   Total   44461128    44461128    100.0000    44461128    0    100.0000    0.0000 
   E-Voting        88026686    83.0742    87714807    311879    99.6457    0.3543 
Public-
Institutions
  Poll   105961488    0    0.0000    0    0    0    0 
  Postal Ballot (if applicable)        0    0.0000    0    0    0    0 
   Total   105961488    88026686    83.0742    87714807    311879    99.6457    0.3543 
   E-Voting        124678    0.7608    120421    4257    96.5856    3.4144 
Public- Non
Institutions
  Poll   16386781    0    0.0000    0    0    0    0 
  Postal Ballot (if applicable)        0    0.0000    0    0    0    0 
   Total   16386781    124678    0.7608    120421    4257    96.5856    3.4144 
   Total   166809397    132612492    79.4994    132296356    316136    99.7616    0.2384 
Whether resolution is Pass or Not.    Yes      

 

Details of Invalid Votes
Category No. of Votes
Promoter and Promoter Group 0
Public Insitutions 0
Public - Non Insitutions 0

 

 

 

 

 


Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Dr Reddys Laboratories Charts.
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Dr Reddys Laboratories Charts.